Mark Mann is a Urologist in Berkeley Heights, New Jersey. Dr. Mann is rated as a Distinguished provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Prostate Cancer, Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, Prostatectomy, and Ureteroscopy. Dr. Mann is currently accepting new patients.

My goal is to make lasting improvements in my patients’ lives and be the go-to guy who is respected for solving the most complex urologic problems. This way, patients and doctors can turn to me knowing I can tackle their urologic needs no matter how big or small. I chose urology because it involves a wide array of surgical problems while allowing me to maintain long-term relationships with patients. I get great satisfaction helping my patients understand their problems. It is important to be able to discuss and offer all treatment options available, both surgical and nonsurgical. If surgery is necessary, I offer the latest, least invasive techniques to return you to your normal life more quickly. Dr. Steinberg is rated as an Advanced provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Hydronephrosis, Ureteroscopy, and Reconstructive Urology Surgery.

Dr. Pressler always strives to provide compassionate and personalized care for all of his patients. He is a recognized regional expert in urologic oncology and robotic surgery. Dr. Pressler has the most experience using the da Vinci robot in northwest NJ. Dr. Pressler specializes in robotic prostatectomy, cystectomy, partial, nephrectomy and urinary tract reconstruction. He is the only urologist in NJ to perform neobladder reconstruction entirely robotic/laparoscopically. Dr. Pressler is rated as an Advanced provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Hydronephrosis, Obstructive Uropathy, Prostate Cancer, Ureteroscopy, and Bladder Reconstruction.

The relationship between patient and physician is a partnership and the best medicine is practiced as part of a team-based approach with patients, their families and their other physicians. As an experienced fellowship-trained, minimally-invasive urologic oncologic surgeon, my role as your advisor is to provide the most effective medical and surgical techniques for the management of prostate, bladder, kidney, testicular and adrenal cancers. This not only takes into account the disease process, but importantly recognizes the effect on quality-of-life on both patients and caregivers during and following treatment. Education and communication are the hallmarks of ensuring that we are part of a successful team together. Dr. Prasad is rated as an Advanced provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Bladder Cancer, Non-Muscle Invasive Bladder Cancer, Prostate Cancer, Prostatectomy, and Nephrectomy.

It’s important to me to connect with my patients on a personal level, which helps me better understand their problems and concerns. I’m genuinely interested in them and their families and improving their quality of life, and I encourage everyone in the practice to treat patients with that same level of compassion. My patients perceive me as an experienced, compassionate urologic surgeon they can rely on. I enjoy treating the entire range of urologic disorders, with a special interest in oncology and kidney problems. Dr. Taylor is rated as an Advanced provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Enlarged Prostate (BPH), Familial Prostate Cancer, Prostate Cancer, Ureteroscopy, and Reconstructive Urology Surgery.

I like to inform and educate my patients to include them in the decision process and intervene only when necessary. I will be facile and choose what’s best for the patient according to the circumstances while listening for the answer — it’s usually in the complaint — and being compassionate. Dr. Kaynan is rated as an Advanced provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are UPJ Obstruction, Urinary Tract Infection in Children, Hydronephrosis, Reconstructive Urology Surgery, and Ureteroscopy.

Heather Katz, DO, FACOI, FACP, is a board-certified hematologist and medical oncologist specializing in the diagnosis and treatment of solid tumors and hematologic malignancies. Her clinical expertise includes cancers of the breast, gastrointestinal tract, head and neck, genitourinary system, lung, and gynecologic organs, as well as hematologic conditions such as leukemia, lymphoma, and multiple myeloma. Dr. Katz is committed to delivering comprehensive, evidence-based care grounded in compassion and respect for each patient’s individual journey. She emphasizes shared decision-making, continuity of care, and clear communication to empower patients and their families throughout treatment and survivorship. Dr. Katz earned her Bachelor of Science in Biology, with a minor in Human Development, from the State University of New York at Geneseo. She received her medical degree from Rocky Vista University College of Osteopathic Medicine in Parker, Colorado, and completed her internal medicine residency at Broward Health Medical Center in Fort Lauderdale, Florida, where she served as Chief Resident and was named Resident of the Year. She went on to complete her fellowship in Hematology and Medical Oncology at Marshall University’s Joan C. Edwards School of Medicine in Huntington, West Virginia, serving as Chief Fellow in her final year. Board certified in Internal Medicine, Medical Oncology, and Hematology by the American Osteopathic Board of Internal Medicine, Dr. Katz is a Fellow of both the American College of Osteopathic Internists and the American College of Physicians. She has presented at numerousnational oncology conferences and is the author of over 15 peer-reviewed publications in the medical literature. Dr. Katz is dedicated not only to clinical excellence but also to advancing the field of oncology through research, education, and mentorship. Her patients recognize her for her thoughtful bedside manner, personalized treatment planning, and unwavering commitment to high-quality care. . Dr. Katz is rated as an Advanced provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. Her top areas of expertise are Posterior Fossa Tumor, Primitive Neuroectodermal Tumor (PNET), WT1-Related Wilms Tumor Syndromes, Clear Cell Sarcoma, and Salpingo-Oophorectomy.

An expert in cancer care, Dr. Ellen Early brings broad-based knowledge and expertise to Atlantic Medical Group. She joins Atlantic Hematology Oncology, a growing team that is housed at Carol G. Simon Cancer Center at Morristown Medical Center. Board certified in internal medicine and medical oncology, Dr. Early diagnoses and treats cancer patients using a multidisciplinary approach, which includes radiation and surgical oncology and incorporates clinicians who work collaboratively to deliver the highest quality cancer care possible. In practice for over 25 years, Dr. Early has particular interest in caring for people with breast and lung cancers. Regarded by patients, families and colleagues for both her expertise and her compassion, Dr. Early strives to educate patients about their condition and discuss how to choose the best individualized treatment plan. Passionate about research, Dr. Early has participated in clinical trials throughout her professional career and utilizes chemotherapies, medications and targeted modalities to treat cancers of the breast and lung. After graduating from Saint Peter's University with a bachelor's of science in Biology, Dr. Early went on to achieve her master's degree in molecular biology at City University of New York in Brooklyn. She attended Georgetown University School of Medicine and performed both her internal medicine residency and her fellowship training in hematology and oncology at Memorial Sloan Kettering Cancer Center. Dr. Early is rated as an Experienced provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. Her top areas of expertise are Paget Disease of the Breast, Breast Cancer, Lung Cancer, Pleuropulmonary Blastoma, and Bone Marrow Aspiration.

Dr. Charles Farber is a board-certified, fellowship-trained oncologist at Atlantic Hematology Oncology located at Morristown Medical Center’s Carol G. Simon Cancer Center. He maintains a broad-based practice, yet focuses on benign and malignant hematology. Dr. Farber also serves as medical director of Oncology Research Network Development for Atlantic Health System. In this role, he works with the system’s Breakthrough Oncology Accelerator partners, Translational Genomics Research Institute (TGen) and OriginCV, to expand cancer research at Morristown Medical Center and throughout Atlantic Health System. This partnership ensures that patients have access to the newest and most exciting drugs and technologies through clinical trials. In addition to receiving multiple Patient’s Choice Awards, Dr. Farber has been recognized as a Top Doctor in the New York Metro Area, and listed in Inside Jersey magazine’s Top Doctors, and Consumers Research Council’s Guide to America’s Top Oncologists. He is regarded by colleagues and patients as a knowledgeable, compassionate and devoted physician and has been providing expert care to the Morristown community for more than 20 years. Dr. Farber attended New York University School of Medicine for his medical degree and performed his residency and fellowship at Weill Cornell Medical Center. He also earned a master’s degree and PhD from New York University’s Graduate School of Arts and Sciences. Dr. Farber chairs Morristown Medical Center’s cancer subcommittee for adolescents and young adults and serves as secretary and treasurer of the Oncology Society of New Jersey. He was former chief of the division of Hematology/Oncology at Morristown Medical Center from 2007 to 2011. Dr. Farber serves as a clinical assistant professor at Rutgers and at the Cancer Institute of New Jersey. His research has been published in the Journal of the American Nutraceutical Association, the New England Journal of Medicine and the National Cancer Institute’s Clinical Trial Directory. Dr. Farber is rated as an Experienced provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Non-Hodgkin Lymphoma, Follicular Lymphoma, and Bone Marrow Aspiration.

William Rafelson, MD, MBA, is a fellowship-trained hematologist-oncologist with Atlantic Medical Group (AMG). Board-certified in Internal Medicine, Hematology, and Medical Oncology by the American Board of Internal Medicine, he has a focus in the management of advanced genitourinary cancers (cancers arising from the bladder, urinary tract, kidney, prostate, or testes), and treats a range of hematologic and oncologic disorders. He believes in providing compassionate care and uses a shared decision-making approach in tailoring the right treatment regimen, whether that is chemotherapy, hormone therapy, or immunotherapy to treat the patient’s disease.After earning his medical degree at the UMDNJ-Robert Wood Johnson Medical School at Camden, NJ, Dr. Rafelson completed an internal medicine residency at The Warren Alpert Medical School of Brown University, Providence, RI, served as a National Institutes of Health (NIH) T32 post-doctoral research fellow at Rhode Island Hospital, also in Providence, followed by fellowship in Hematology/Oncology, again at Warren Alpert School of Medicine. He also holds an MBA from the Heller School for Social Policy and Management, Brandeis University, Waltham, MA. Prior to joining AMG, he served as assistant attending in the Solid Tumor Genitourinary Oncology service at Memorial Sloan Kettering Cancer Center in Middletown, NJ, and served on the inpatient genitourinary service in Memorial Hospital in New York City.The author of multiple publications in peer-reviewed medical journals, Dr. Rafelson has also written several chapters in medical textbooks, including Ferri’s Clinical Advisor. He won a National Research Service Postdoctoral Award from the NIH and was one of just 15 medical oncologists nationally to be selected for a Rising Star Award from Castle Connolly. He was selected as one of “Jersey’s Best” medical oncologists in 2022 and 2023.Prior to joining AMG, Dr. Rafelson served as Instructor of Medicine and, later, Assistant Professor of Medicine at Weill Cornell Medical College, Cornell University, New York City, teaching first- and second-year medical students. He is a member of the American Society for Clinical Oncology and the American College of Physicians. He attends the MSKCC Annual Hematology-Oncology Review as well as ASCO annual conferences yearly to apply the most up-to-date information in his specialty. Dr. Rafelson is a participating provider of the Atlantic Accountable Care Organization. Dr. Rafelson is rated as an Experienced provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Muscle Invasive Bladder Cancer, and Urothelial Cancer.

Karim R. Saab, MD, is a fellowship-trained hematology oncology specialist with Atlantic Medical Group Hematology Oncology. Triple board-certified in internal medicine, medical oncology, and hematology by the American Board of Internal Medicine, Dr. Saab has years of teaching experience and clinical knowledge.After graduating with distinction from the School of Medicine at the American University of Beirut, Lebanon, Dr. Saab served as a research scholar and postdoctoral research fellow in the Department of Surgery at St. Jude Children’s Research Hospital, Memphis, TN, followed by two years as a postdoctoral research fellow at Harvard Medical School, Brigham and Women’s Hospital, and Children’s Hospital Boston, Transplantation Research Center, Boston, MA. He performed his residency in internal medicine at the University of Colorado, Aurora, CO, where he was awarded the internal medicine resident research publication award, followed by a fellowship in hematology and medical oncology at Weill Cornell Medical College / New York-Presbyterian Hospital, New York, NY.Before joining Atlantic Medical Group Hematology Oncology, Dr. Saab worked at Hennepin Healthcare in Minneapolis, MN, where he also served as assistant professor of medicine at the University of Minnesota. Dr. Saab has been involved in teaching hematology and medical oncology fellows, residents, medical and physician assistant students, as well as teaching medical students at Weill Cornell Medical College. Actively involved in research, Dr. Saab has studied biomarkers for diagnosis, disease progression and response to therapy; cancer stem cell biology; and antiangiogenic therapy for solid tumors. He has been published in many peer-reviewed journals and presented at national conferences.Dr. Saab is an active member of the American Society of Clinical Oncology, American Society of Hematology, American College of Physicians, and American Physician Scientists Association. He is fluent in French and Arabic. Dr. Saab is a participating provider of the Atlantic Accountable Care Organization. Dr. Saab is rated as an Experienced provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Non-Small Cell Lung Cancer (NSCLC), ALK-Positive Non-Small Cell Lung Cancer, Lung Adenocarcinoma, and Small Cell Lung Cancer (SCLC).

Sarada Gurubhagavatula is a Hematologist and an Oncologist in Morristown, New Jersey. Dr. Gurubhagavatula is rated as an Experienced provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. Her top areas of expertise are Small Cell Lung Cancer (SCLC), ALK-Positive Non-Small Cell Lung Cancer, Squamous Cell Lung Carcinoma, and Lung Adenocarcinoma. Dr. Gurubhagavatula is currently accepting new patients.

Seyoung Han, MD, is a fellowship-trained hematologist/oncologist with Advanced Care Oncology and Hematology (ACOHA), part of Atlantic Medical Group (AMG). Board-certified in internal medicine, hematology and medical oncology by the American Board of Internal Medicine, he has comprehensive experience and specialized training in treating blood diseases and various forms of cancer. Dr. Han’s clinical interests include lung, breast, GI, and hematologic cancers. He also participates in clinical trials as a principal investigator.Dr. Han meticulously analyzes each patient’s test results, takes detailed notes on their medical history, and performs thorough physical examinations in order to determine the most appropriate treatment options for each of his patients. He values informed decision-making to help patients maintain their quality of life. He provides patient-centered compassionate care and ensures that his patients have a full understanding of their condition and provides evidence-based treatment options.After earning his medical degree at Kyung Hee University College of Medicine in South Korea, and a compulsory three-year hitch in military service, Dr. Han performed an internal medicine residency at Saint Francis Hospital, now called Ascension Saint Francis Hospital, in Evanston, IL. After completing his residency, he served as an assistant professor and an attending physician at Southern Illinois University, then joined the bone marrow transplant program as a hospitalist and clinical instructor at Washington University in St. Louis, MO. Dr. Han then pursued advanced training with a fellowship in hematology-oncology at the University of Minnesota in Minneapolis. He was honored with an award as an outstanding fellow from the Minnesota Society of Oncology for two consecutive years. Following his fellowship, Dr. Han joined ACOHA in 2020.Fluent in English and Korean, Dr. Han is a member of the American Society of Hematology, the American Society of Clinical Oncology, the American College of Physicians, the Society of Hospital Medicine, and the Korean Medical Association. He is a participating provider of the Atlantic Accountable Care Organization. Dr. Han is rated as an Experienced provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Thrombocytopenia, Pleuropulmonary Blastoma, Paget Disease of the Breast, Pulmonary Embolism, and Bone Marrow Aspiration.

Dr. Chaikin completed his residency in Urology at the Hospital of the University of Pennsylvania, and his fellowship in Female Pelvic Medicine and Reconstructive Surgery under Director Jerry G. Blaivas. He is a past Chairman of Urology at Morristown Medical Center, and currently serves as an Assistant Professor of Urology at Weill Cornell Medical College. He is board certified in both urology and female pelvic medicine & reconstructive surgery. His special areas of interest include urogynecology; male and female incontinence; genital prolapse; and neurologic disorders affecting the bladder. Dr. Chaikin’s approach to healthcare is to be cutting edge, compassionate, and to put the patient first. He strives to provide high quality, comprehensive and compassionate care using the most advanced treatments. He believes in complete dedication to each individual patient. Dr. Chaikin is rated as an Experienced provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are UPJ Obstruction, Kidney Stones, Boils, Ureteroscopy, and Prostatectomy.

My experience as a fellowship-trained urologic oncologist has taught me that optimizing medical care is a combination of incorporating evidence-based practices with a strong multidisciplinary team. I have always had deep compassion for patients as well as a curiosity about the science behind disease diagnosis, treatment, and prevention. There is great potential to both cure and improve the quality of life for patients with urologic disease. My training with leaders in the field of open and robotic surgery, pharmacotherapy, and integrative treatments has given me a dynamic toolset to address all of a patient’s needs. I offer minimally invasive surgery for a wide variety of malignant and benign urologic conditions to help patients recover quickly and allow them to spend more time on things that matter to them. Dr. Taylor is rated as an Experienced provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Prostate Cancer, Muscle Invasive Bladder Cancer, Familial Prostate Cancer, Nephrectomy, and Ureteroscopy.

I have been blessed to have received some of the finest urologic training available in the United States. My teachers and mentors at Cornell and Harvard have influenced me to simply be the best physician, surgeon, and person that I can be. I love my profession and cherish the opportunity to help the people of my community every day that I am in the office, hospital or operating room. I strive to treat every patient I see as if they were a family member and feel that a compassionate and individualized approach to health care is paramount in achieving the finest outcomes for my patients.Dr. Sutaria is one of the region’s top Robotic and minimally invasive surgeons and has trained other surgeons in the use of the Robotic Technology. Dr. Sutaria is rated as an Experienced provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Obstructive Uropathy, Kidney Stones, Boils, Ureteroscopy, and Bladder Reconstruction.

Rajen Butani is a Urologist in Berkeley Heights, New Jersey. Dr. Butani is rated as a Distinguished provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Obstructive Uropathy, Vasectomy, and Reconstructive Urology Surgery. Dr. Butani is currently accepting new patients.

Jayram Krishnan is a Urologist in Berkeley Heights, New Jersey. Dr. Krishnan is rated as a Distinguished provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Bladder Cancer, Non-Muscle Invasive Bladder Cancer, Muscle Invasive Bladder Cancer, Nephrectomy, and Reconstructive Urology Surgery. Dr. Krishnan is currently accepting new patients.

Douglas Berkman is a Urologist in Berkeley Heights, New Jersey. Dr. Berkman is rated as a Distinguished provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Obstructive Uropathy, Bilateral Hydronephrosis, UPJ Obstruction, Vasectomy, and Reconstructive Urology Surgery. Dr. Berkman is currently accepting new patients.

Muhammad Abbasi is a Hematologist and an Oncologist in Morristown, New Jersey. Dr. Abbasi is rated as an Experienced provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Colorectal Cancer, Paget Disease of the Breast, Familial Colorectal Cancer, Childhood Iron Deficiency Anemia, and Bone Marrow Aspiration. Dr. Abbasi is currently accepting new patients.